Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Jacobs

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam ResistancePatricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Cancers|April 12, 2022
Energy Sources for Exosome Communication in a Cancer MicroenvironmentAbhimanyu Thakur, Amanda Johnson, Emily Jacobs, et al.
Peerj|April 16, 2020
A halo of reduced dinoflagellate abundances in and around eelgrass bedsEmily Jacobs-Palmer, Ramón Gallego, Ana Ramón-Laca, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2025
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?Kimberly C Claeys, Patricia J Simner, Tsigereda Tekle, et al.
Journal of Clinical Microbiology|June 30, 2025
Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints for <i>Pseudomonas</i> other than <i>Pseudomonas aeruginosa</i>Patricia J Simner, Harley Harris, Emily Jacobs, et al.
Pediatric Blood & Cancer|August 21, 2019
Correlates of successful transition in young adults with sickle cell diseaseIsha Darbari, Emily Jacobs, Olivia Gordon, et al.
Open Forum Infectious Diseases|October 23, 2025
Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care UnitSima L Sharara, Patricia J Simner, Yehudit Bergman, et al.
Journal of Clinical Microbiology|April 30, 2025
Defining antimicrobial susceptibility testing methods and breakpoints among <i>Achromobacter</i> speciesHarley Harris, Haley Stambaugh, Emily Jacobs, et al.
Open Forum Infectious Diseases|September 2, 2025
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream InfectionsDariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?Dariusz A Hareza, Sara E Cosgrove, Patricia J Simner, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam ResistancePatricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Cancers|April 12, 2022
Energy Sources for Exosome Communication in a Cancer MicroenvironmentAbhimanyu Thakur, Amanda Johnson, Emily Jacobs, et al.
Peerj|April 16, 2020
A halo of reduced dinoflagellate abundances in and around eelgrass bedsEmily Jacobs-Palmer, Ramón Gallego, Ana Ramón-Laca, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2025
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?Kimberly C Claeys, Patricia J Simner, Tsigereda Tekle, et al.
Journal of Clinical Microbiology|June 30, 2025
Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints for <i>Pseudomonas</i> other than <i>Pseudomonas aeruginosa</i>Patricia J Simner, Harley Harris, Emily Jacobs, et al.
Pediatric Blood & Cancer|August 21, 2019
Correlates of successful transition in young adults with sickle cell diseaseIsha Darbari, Emily Jacobs, Olivia Gordon, et al.
Open Forum Infectious Diseases|October 23, 2025
Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care UnitSima L Sharara, Patricia J Simner, Yehudit Bergman, et al.
Journal of Clinical Microbiology|April 30, 2025
Defining antimicrobial susceptibility testing methods and breakpoints among <i>Achromobacter</i> speciesHarley Harris, Haley Stambaugh, Emily Jacobs, et al.
Open Forum Infectious Diseases|September 2, 2025
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream InfectionsDariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?Dariusz A Hareza, Sara E Cosgrove, Patricia J Simner, et al.
Pageof 7